1-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1-pentanone, 95.0%, 1g

1-(1-Methylethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 500mg

Oxetan-3-ylmethanol, 95.0%, 10g

6-BROMO-2-METHYL-1,2,3,4-TETRAHYDRO-QUINOLIN-4-OL, 95.0%, 1g

Salicilato de sodio, mínimo 99 %, PA, 250 g, envase de plástico.

O-(t-butyldimethylsilyl)hydroxylamine, 95%, 90+%, 5g

5-Bromo-1-methyl-1H-indole-3-carboxylic acid, 95.0%, 1g

Boc-Leu-OH, 98%, 25g

5-(4-Bromophenyl)-3-methyl-1H-pyrazole, 95.0%, 10g

Tapas de cierre, Gesch. frontal, Ø 25 mm 500 uds.

4-Bromo-7-methyl-2,3-dihydro-1H-inden-1-one, 95.0%, 1g

(R)-3-((tert-Butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid, 98%, 1g

4,7-DIHYDRO-IMIDAZOLE[4,5-D]1,3-DIAZEPINE-8(1H)-ONE HCL, 95.0%, 100mg